These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
364 related items for PubMed ID: 16166313
1. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Perri SR, Nalbantoglu J, Annabi B, Koty Z, Lejeune L, François M, Di Falco MR, Béliveau R, Galipeau J. Cancer Res; 2005 Sep 15; 65(18):8359-65. PubMed ID: 16166313 [Abstract] [Full Text] [Related]
2. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Tanaka T, Cao Y, Folkman J, Fine HA. Cancer Res; 1998 Aug 01; 58(15):3362-9. PubMed ID: 9699667 [Abstract] [Full Text] [Related]
6. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma. Kim SM, Lim JY, Park SI, Jeong CH, Oh JH, Jeong M, Oh W, Park SH, Sung YC, Jeun SS. Cancer Res; 2008 Dec 01; 68(23):9614-23. PubMed ID: 19047138 [Abstract] [Full Text] [Related]
7. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice]. Sun W, Jiang Z, Xiang TX, Tao XH, Huang AL, Wang PL. Zhonghua Yi Xue Za Zhi; 2009 Mar 31; 89(12):841-5. PubMed ID: 19595126 [Abstract] [Full Text] [Related]
9. A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer. Matsuda KM, Madoiwa S, Hasumi Y, Kanazawa T, Saga Y, Kume A, Mano H, Ozawa K, Matsuda M. Cancer Gene Ther; 2000 Apr 31; 7(4):589-96. PubMed ID: 10811477 [Abstract] [Full Text] [Related]
11. Increased suppression of oncolytic adenovirus carrying mutant k5 on colorectal tumor. Fan JK, Xiao T, Gu JF, Wei N, He LF, Ding M, Liu XY. Biochem Biophys Res Commun; 2008 Sep 19; 374(2):198-203. PubMed ID: 18621025 [Abstract] [Full Text] [Related]
12. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization. Cai W, Ma J, Li C, Yang Z, Yang X, Liu W, Liu Z, Li M, Gao G. J Cell Biochem; 2005 Dec 15; 96(6):1254-61. PubMed ID: 16167344 [Abstract] [Full Text] [Related]
14. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Ji WR, Barrientos LG, Llinás M, Gray H, Villarreal X, DeFord ME, Castellino FJ, Kramer RA, Trail PA. Biochem Biophys Res Commun; 1998 Jun 18; 247(2):414-9. PubMed ID: 9642142 [Abstract] [Full Text] [Related]
15. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells. Read TA, Farhadi M, Bjerkvig R, Olsen BR, Rokstad AM, Huszthy PC, Vajkoczy P. Cancer Res; 2001 Sep 15; 61(18):6830-7. PubMed ID: 11559558 [Abstract] [Full Text] [Related]
16. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. MacDonald NJ, Murad AC, Fogler WE, Lu Y, Sim BK. Biochem Biophys Res Commun; 1999 Oct 22; 264(2):469-77. PubMed ID: 10529387 [Abstract] [Full Text] [Related]
17. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene. Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K. Hepatology; 2003 Mar 22; 37(3):696-704. PubMed ID: 12601367 [Abstract] [Full Text] [Related]